🚨URGENTE! A ANPG @uneoficial e @ubesoficial impetraram MANDADO DE SEGURANÇA COLETIVO no STF contra o decreto de Bolsonaro que bloqueia os recursos e impede o pagamento dos bolsistas da CAPES e médicos-residentes. O ato é ILEGAL pois viola direito líquido e certo dos bolsistas.👇🏿
A @CAPES_Oficial viabilizou a contratação de dezenas de alunos de pós-graduação para realizarem suas pesquisas no CQMED. Sem este apoio, possivelmente este Centro não existiria.
Por esta razão apoiamos a liberação de recursos urgentemente para o pagamento das bolsas.
Menos risco, mais efetivo e melhor acesso. Rumo à combinação ideal. @DNDi_Portugues
Drug combination offers shorter, more effective visceral leishmaniasis treatment https://t.co/dGKCtMLVrq
Here's the slide that took me 6 months to make. The six classes of molecular interactions for drug design. Clearly H-bonds are the first thing to master as a drug designer followed by pi-pi and sigma-sigma interactions.
Just over a week left to apply for our Drug Discovery Mission course in Brazil. Will your team have what it takes to find that new compound?? Find out!
@danielgedder from the @qhetemlab was there. Check the video to meet him and the organizers, and learn more about the beautiful work done by @WCAIRDundee
Report: UK's main laboratory for zoonotic pathogens underfunded: https://t.co/0mJvQhio6E
In 2021 SCIF's @gabrielle9 and @RSTMH's @TamarGhosh analysed advice from 137 experts to G7 leaders on cross-sector, #OneHealth action against new pandemics: https://t.co/0mJvQhio6E
#BeatNTDs
I am thrilled to announce that the 2nd Winter In-Person Organic Symposium (WIPOS 2022, @WIPOS2022) will take place between December 19-22, 2022 in Honolulu, HI. The speaker lineup is spectacular: https://t.co/zwYKp3Lw1l. Register at https://t.co/eFa9nhzlZB. Max. 150 attendees.
We're excited to announce the rest of the speakers included in the #H3DSymposium2022 Programme!
For more information on registering for the Symposium and to apply for #bursaries, please visit our website: https://t.co/ltj7aDJ6Bi